174 related articles for article (PubMed ID: 1721328)
21. Immunophilins, ligands, and the control of signal transduction.
Schreiber SL; Crabtree GR
Harvey Lect; 1995-1996; 91():99-114. PubMed ID: 9127988
[No Abstract] [Full Text] [Related]
22. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
Sharkey J; Butcher SP
Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
[TBL] [Abstract][Full Text] [Related]
23. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
[No Abstract] [Full Text] [Related]
24. Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens.
Propper DJ; Woo J; Macleod AM; Catto GR; Thomson AW
Transplant Proc; 1993 Feb; 25(1 Pt 1):673-4. PubMed ID: 7679837
[No Abstract] [Full Text] [Related]
25. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
Mattila PS
Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
[No Abstract] [Full Text] [Related]
26. Gene expression of FK 506-binding protein.
Kar S; Carr B
Transplant Proc; 1991 Dec; 23(6):2880-2. PubMed ID: 1721303
[No Abstract] [Full Text] [Related]
27. Effect of immunosuppressive drugs (CsA, FK 506, rapamycin) on the kidney microsomal cytochrome P-450 system in the rat.
Yoshimura R; Yoshimura N; Ohmachi T; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
Transplant Proc; 1994 Oct; 26(5):2890. PubMed ID: 7524223
[No Abstract] [Full Text] [Related]
28. FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function.
Pelekanou V; Trezise AE; Moore AL; Kay JE
Transplant Proc; 1991 Dec; 23(6):3200-1. PubMed ID: 1721408
[No Abstract] [Full Text] [Related]
29. Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.
Zheng B; Shorthouse R; Masek MA; Berry G; Billingham ME; Morris RE
Transplant Proc; 1991 Feb; 23(1 Pt 1):851-5. PubMed ID: 1703717
[No Abstract] [Full Text] [Related]
30. Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin.
Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
Transplant Proc; 1994 Apr; 26(2):851-4. PubMed ID: 7513476
[No Abstract] [Full Text] [Related]
31. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
Cooper MH; Gregory SH; Thomson AW; Fung JJ; Starzl TE; Wing EJ
Transplant Proc; 1991 Dec; 23(6):2957-8. PubMed ID: 1721326
[No Abstract] [Full Text] [Related]
32. FK-506--a novel immunosuppressant.
Parsons WH; Sigal NH; Wyvratt MJ
Ann N Y Acad Sci; 1993 Jun; 685():22-36. PubMed ID: 7689805
[No Abstract] [Full Text] [Related]
33. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma.
Dumont FJ; Staruch MJ; Grammer T; Blenis J; Kastner CA; Rupprecht KM
Cell Immunol; 1995 Jun; 163(1):70-9. PubMed ID: 7538911
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin.
Carlson RP; Sehgal SN; Lewis AJ
Clin Exp Rheumatol; 1993; 11 Suppl 8():S129. PubMed ID: 8324938
[No Abstract] [Full Text] [Related]
35. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
[No Abstract] [Full Text] [Related]
36. Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
Sigal NH; Dumont FJ; Siekierka JJ; Wiederrecht G; Parent SA; Brizuela L
Transplant Proc; 1991 Dec; 23(6):2846-9. PubMed ID: 1721295
[No Abstract] [Full Text] [Related]
37. Purification of a 50- to 58-kDa immunophilin from human spleen and a Jurkat T-cell line capable of binding cyclosporine A, FK 506, and rapamycin.
Donnelly JG; Soldin SJ
Transplant Proc; 1991 Dec; 23(6):2886-9. PubMed ID: 1721305
[No Abstract] [Full Text] [Related]
38. Molecular mechanisms of immunosuppressive agents.
Borel JF; Baumann G
Bull Mem Acad R Med Belg; 1994; 149(1-2):97-101; discussion 101-3. PubMed ID: 7531051
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin effects on immunologic reconstitution.
Vogelsang GB; Hess AD
Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
[No Abstract] [Full Text] [Related]
40. Effects of rapamycin on hematopoiesis.
Quesniaux VF; Wehrli S; Wioland C; Schuler W; Schreier MH
Transplant Proc; 1994 Dec; 26(6):3135-40. PubMed ID: 7998093
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
